ReportGem ReportGem EN

普通外文研报

F3Q26 Preview: Integrations Advancing, but Organic NNARR the Number to Watch

发布日期: 2026-05-20研究机构: Cantor Fitzgerald公司 / 股票: PANW.OQ报告页数: 14原文语言: 英语证据页码: 2

研报英文原文证据摘录

F3Q26 Preview: Integrations Advancing, but Organic NNARR the Number to Watch

May 20, 2026

differences in ARR methodology. We forecast ~$358M in

organic net new NGS ARR in F3Q, and believe this is the metric

that will drive sentiment around the stock, with investors less

likely to give Palo credit for inorganic outperformance.

○In our view, one underappreciated angle is Venafi. The

acquisition brought certificate lifecycle and machine identity

capabilities that management plans to deliver to Palo's

65,000+ firewall customers. We view this motion as one of

the more tangible near term upside opportunities to monitor,

while broader platform cross-sell will likely take longer to

integrate.

●Chronosphere Expansion. In January, Palo Alto completed its

acquisition of Chronosphere, a next-generation observability platform.

Chronosphere, recognized as a Leader in the 2025 Gartner Magic

Quadrant for Observability Platforms, contributed ~$200M in ARR in

F2Q. Management also highlighted a multi-year nine figure expansion

with a leading AI model provider in the quarter, underscoring

Chronosphere's traction with AI-native infrastructure buyers. In F3Q,

we are watching for evidence of product integration, including

Chronosphere’s work with Cortex AgentiX to enable agents for

observability workflows and the integration of Calyptia into XSIAM

to support security data pipelining. Both represent paths to product

differentiation vs. standalone observability vendors.

●Continued Platform Success. Palo Alto added ~110 new platformized

customers in F2Q26, up 35% y/y. Large customer growth remained

strong, with customers generating >$5M in NGS ARR increasing 48%

y/y to 173, while customers generating >$10M in NGS ARR increased

50% y/y to 60. We believe cybersecurity consolidation remains in the

本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。

打开研报阅读器